Amazon Braket users can employ Nvidia's open-source quantum development platform to develop hybrid workflows using the CUDA-Q ...

Intelligent Omics' Dr Rob Grundy discusses how combining AI with big data can lead to better drug discovery processes and that partnerships can help more organisations leverage cutting-edge tools.

Standardising analytical data is the key to unlocking AI-driven innovation in chemical and pharmaceutical research. Richard Lee, Director, Core Technology and Capabilities at ACD/Labs explores how ...

Scientific Computing World is hosting a virtual roundtable in February for research leaders, scientists and R&D experts in drug discovery, particularly those working with new modalities, such as RNA ...

Scientific Computing World is hosting a virtual roundtable in February for research leaders, scientists and R&D experts in drug discovery, particularly those working with new modalities, such as RNA ...

His research explores the rise of generative AI and accelerated use of AI more broadly to advance drug and scientific discovery. Reuben leads Gartner's coverage of genomics, multiomics, cell and gene ...

The European Commission has awarded the Strategic Technologies for Europe Platform (STEP) Seal to the multilingual AI project OpenEuroLLM – the first Digital Europe Programme-funded project to receive ...

The two companies are working to integrate LightSolver’s technology with Ansys LS-DYNA nonlinear dynamics structural simulation software to accelerate simulations for automotive and aerospace ...

Action Summit in Paris, Commission President Ursula von der Leyen has launched InvestAI, an initiative to mobilise €200 billion for investment in AI, including a new European fund of €20 billion for ...

Oxford Economics released a quantum economic report stating quantum computing could add £200 billion to the UK economy by ...

Scientific Computing World is hosting a virtual roundtable in February for research leaders, scientists and R&D experts in drug discovery, particularly those working with new modalities, such as RNA ...

Tim Doggett is the CEO of the Chemical Business Association where he advocates for the sector in the UK and across the world. Doggett: My background is in supply chain logistics. I've worked in the UK ...